SGLT2 Inhibitors Reduce Heart Failure Hospitalization and Cardiovascular Death Clarity and Consistency

被引：3
|
作者：
Wiviott, Stephen D. [1 ,2 ]
Berg, David D. [1 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, TIMI Thrombolysis Myocardial Infarct Study Grp, Boston, MA USA
[2] Brigham & Womens Hosp, TIMI Thrombolysis Myocardial Infarct Study Grp, 60 Fenwood Rd,Suite 7022, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 81卷 / 25期
关键词：
cardiovascular death; clinical trials; heart failure; meta-analysis; sodium-glucose cotransporter-2 inhibitors;
D O I：
10.1016/j.jacc.2023.04.035
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Cardiovascular outcome in patients treated with SGLT2 inhibitors for heart failure: a meta-analysis
    Gager, G. M.
    Gelbenegger, G.
    Jilma, B.
    Von Lewinski, D.
    Sourij, H.
    Eyileten, C.
    Filipiak, K.
    Postula, M.
    Hengstenberg, C.
    Siller-Matula, J.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1051 - 1051
  • [42] The SGLT2 inhibitor Empagliflozin shown to reduce hospitalizations for heart failure
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2016, 18 (01): : 110 - 110
  • [43] SGLT2 inhibitors for heart and kidney
    van der Giet, Markus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (22) : 1456 - 1461
  • [44] SGLT-2 Inhibitors Reduce Heart Failure-Related Hospitalization in Patients Without Diabetes
    Shaughnessy, Allen F.
    AMERICAN FAMILY PHYSICIAN, 2022, 106 (04) : 461 - 462
  • [45] Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure
    Sinha, Binayak
    Ghosal, Samit
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 150 : 8 - 16
  • [46] SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failure
    Gupta, Rahul
    Maitz, Theresa
    Egeler, David
    Mehta, Anila
    Nyaeme, Mark
    Hajra, Adrija
    Goel, Akshay
    Sreenivasan, Jayakumar
    Patel, Neel
    Aronow, Wilbert S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (08) : 479 - 486
  • [47] Role of SGLT2 Inhibitors in Patients with Diabetes Mellitus and Heart Failure
    Verbrugge F.H.
    Current Heart Failure Reports, 2017, 14 (4) : 275 - 283
  • [48] Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors
    Evans, Marc
    Morgan, Angharad R.
    Yousef, Zaheer
    Ellis, Gethin
    Dashora, Umesh
    Patel, Dipesh C.
    Brown, Pam
    Hanif, Wasim
    Townend, Johnathan N.
    Kanumilli, Naresh
    Moore, Jim
    Wilding, John P. H.
    Bain, Stephen C.
    DRUGS, 2021, 81 (11) : 1243 - 1255
  • [49] Eligibility and reimbursement of SGLT2 inhibitors in a heart failure outpatient cohort
    Tarantini, Roberto
    Vecchi, Andrea Lorenzo
    Matteo, Federica
    Guerci, Marco
    De Ponti, Roberto
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G) : G125 - +
  • [50] SGLT2 Inhibitors Should Be Considered for All Patients With Heart Failure
    Ahmad, Tariq
    Desai, Nihar R.
    Velazquez, Eric J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (14) : 1311 - 1313
12345